Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy
admin The biopharmaceutical landscape is alive with significant clinical advancements and market forecasts, highlighted this week...
biotech
Andy Plump to Retire from Takeda in 2027, Marking the End of a Transformative R&D Era
Andy Plump, the influential President of Research & Development at Takeda Pharmaceutical Company, is set...
Johns Hopkins Pathologist Awarded CRI STAR Grant to Pioneer AI-Driven Precision Oncology
The landscape of cancer treatment is undergoing a profound transformation, shifting from a generalized approach...
FDA Imposes Clinical Hold on Biohaven’s Epilepsy Drug Opakalim, Weeks After $795 Million Licensing Deal
The U.S. Food and Drug Administration (FDA) has placed a clinical hold on the RISE-2...
Biotech’s Reverse Merger Renaissance: From Last Resort to Wall Street Fast Track
In the sophisticated boardrooms of law firms and the bustling trading floors of investment banks,...
Safeguarding Your Skin: A Comprehensive Look at UV Radiation, Skin Cancer Prevention, and Immunotherapy Advances
July marks Ultraviolet (UV) Radiation Safety Awareness Month, a critical period for public health organizations...
FDA Secures Key Leadership with Permanent Appointments to CDER and CBER, Signaling Stability Amidst Prior Turmoil
After nearly two tumultuous years marked by significant turnover in its upper echelons, the U.S....
Tyra Biosciences’ Dabogratinib Phase 2 Results Disappoint Wall Street, Yet Analysts See Path Forward in Non-Muscle Invasive Bladder Cancer
San Diego, CA – September 9, 2026 – Tyra Biosciences, a clinical-stage biotechnology company, saw...
Kura spins diabetes work into a Lilly-backed biotech startup
Caspian Therapeutics, a newly launched biotechnology startup, is poised to make a significant impact in...
Solstice Oncology Advances Novel CTLA-4 Inhibitor, Aiming to Revolutionize Treatment for ‘Cold’ Tumors and Address Past Immunotherapy Challenges
Solstice Oncology, a burgeoning player in the biotechnology sector, is making significant strides in cancer...
